GDTC - CIK 0001873093
The table below shows CytoMed Therapeutics Ltd's income statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of revenue | - | - | - | - |
| Gross profit | - | - | - | - |
| R&D | $1.72M | $1.40M | $1.20M | $1.14M |
| SG&A | - | - | - | - |
| Operating income | - | - | - | - |
| Income tax |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| Net income | - | - | - | - |
| EPS (diluted) | - | - | - | - |